Last updated: 2026-09-15 01:45:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $163.74, with a market capitalization of $248.41B and a P/E ratio of 111.84. Over the past 52 weeks, its price has ranged from $145.79 to $212.71. This page covers its latest market performance, valuation, price trends and company information.
$248.41B | |
$164.08 | |
$212.71 | |
$29.96 | |
$160.17 | |
2.93M | |
3.22M | |
111.84 | |
$212.71 | |
$145.79 | |
1.43% | |
-- |
AstraZeneca PLC (AZN) last closed at $160.17 as of 2026-09-15 00:01:00, unchanged from the previous close of $160.17.
During the latest regular trading session, AZN traded between $29.96 and $212.71, with a volume of 2.93M shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, AstraZeneca PLC (AZN) moved from $161.63 to $163.74, representing a gain of 1.30% ($2.11).
The stock traded between $156.74 and $165.74 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 3.28 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 26.8%
AZN is currently trading at $163.74, placing it 26.8% of the way from its 52-week low of $145.79 to its 52-week high of $212.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
| Employees | 96100 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.